Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation
Christoph U Correll,1–3 Rakesh Jain,4 Jonathan M Meyer,5 Antonia Periclou,6 Timothy Carrothers,6 Ágota Barabássy,7 Mehul Patel,8 Willie Earley91Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, USA; 2Hofstra Northwell School of M...
Main Authors: | Correll CU, Jain R, Meyer JM, Periclou A, Carrothers T, Barabássy Á, Patel M, Earley W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/relationship-between-the-timing-of-relapse-and-plasma-drug-levels-foll-peer-reviewed-article-NDT |
Similar Items
-
Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)
by: Nakamura T, et al.
Published: (2016-01-01) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
by: Aubel T
Published: (2021-07-01) -
Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
by: Aleksandr M. Reznik, et al.
Published: (2020-10-01) -
Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
by: Citrome L
Published: (2018-10-01) -
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
by: Barabássy Á, et al.
Published: (2021-04-01)